Completed Study of the Glutaminase Inhibitor CB-839 in Solid Tumors NCT02071862 Conditions Adenocarcinoma, Adenoma, Breast Diseases, +38 more Locations UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States Stanford University Medical Center — Stanford, California, United States Florida Cancer Specialists — Sarasota, Florida, United States Winship Cancer Institute of Emory School of Medicine — Atlanta, Georgia, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
